Live Price
Live Volume
Chart Volume 0
Volume 0
5 secEnliven Therapeutics Market Segments
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
+0.06(+0.13%)
| Open | $47.25 |
|---|---|
| Close | $47.31 |
| Low | $47.24 |
| Low Change | -0.01 (-0.02%) |
| High | $47.31 |
| High Change | +0.06 (+0.13%) |
| Range | $0.07 |
| Volume | 1.864M |
| Dollar Volume | $88.20M |
Regular Trading Hours Yesterday
+1.56(+3.41%)
| Open | $45.74 |
|---|---|
| Close | $47.30 |
| Low | $44.21 |
| Low Change | -1.53 (-3.34%) |
| High | $47.31 |
| High Change | +1.57 (+3.43%) |
| Range | $3.10 |
| Volume | 831.509K |
| Dollar Volume | $39.33M |
Premarket Yesterday
+0.00(+0.00%)
| Open | $45.74 |
|---|---|
| Close | $45.74 |
| Low | $45.74 |
| Low Change | 0.00 (0.00%) |
| High | $45.74 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 481 |
| Dollar Volume | $22.00K |
Enliven Therapeutics News
Enliven Therapeutics Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Enliven Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $45.21 |
|---|---|
| 10 Day Moving Average (SMA10) | $43.96 |
| 20 Day Moving Average (SMA20) | $41.97 |
| 50 Day Moving Average (SMA50) | $47.80 |
| 100 Day Moving Average (SMA100) | $50.66 |
| 200 Day Moving Average (SMA200) | $43.02 |
Enliven Therapeutics Statistics
| Average Volume (30 Days) | 1.39M |
|---|---|
| P/E Ratio (Current) | -28.26 |
| EPS (Current) | -$1.45 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$67.04M |
| Cash Ratio | 9.57 |
| Current Ratio | 64.07 |
| Quick Ratio | 64.07 |
| Debt to Equity | 0.00 |
| Enterprise Value | $2.87B |
| EV to EBITDA | -23.07 |
| EV to Sales | — |
| Price to Book | 3.35 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.12% |
| Return on Equity | -0.12% |
Enliven Therapeutics Stock Splits
There have been no stock splits for Enliven Therapeutics (ELVN).
Enliven Therapeutics Dividends
There have been no dividends for Enliven Therapeutics (ELVN).